Allergy Diagnostics Market Segmentation by Product & Service (Assay Kits, Instruments, Services, and Consumables); by Tests (In-Vivo Tests and In-Vitro Tests); by Allergens (Inhaled Allergens, Food Allergens, Drug Allergens, and Others); and by End-Users (Diagnostic Laboratories, Hospital-Based Laboratories, Academic Research Institutes, and Others)-Global Demand Analysis & Opportunity Outlook 2031
-
Product Code:
RP-ID-10070617 -
Published Date:
21 Oct 2022 -
Region:
Global
-
Category:
Healthcare & Pharmaceuticals -
Publisher:
Pub-ID-54
Impact Analysis on the Growth of Market
Inflation and Looming Recession to Haunt Businesses:
In 2022 & 2023, market players expected to sail in rough waters; might incur losses due to huge gap in currency translation followed by contracting revenues, shrinking profit margins & cost pressure on logistics and supply chain. Further, U.S. economy is expected to grow merely by 3% in 2022.
....
The Research Report is Updated with 2022 Base Year, 2023 Estimated year and Forecast till 2035 with Market Insights.
With the dip in global production, the GDP has contracted in 2020 and impacted the market across the world. Upon placing a Sample Request, you will receive an updated report with 2022 as base year, 2023 as estimated year and forecast to 2035. This will have market drivers, recovery rate in the market, insights and competitive analysis.
Market Overview:
Translate Report
Global Allergy Diagnostics Market Highlights Over 2022 - 2031
The global allergy diagnostics market generated a revenue figure of approximately USD 5.2 billion in the year 2021 and is expected to generate significant revenue towards the end of the year 2031, by growing at a CAGR of ~13% over the forecast period, i.e., 2022 – 2031. The growth of the market can be attributed to the increasing prevalence of allergic diseases, developing healthcare infrastructures, and increasing disposable income. In addition, rising environmental pollution levels, supportive aids from organizations in allergy diagnostics, and improvement in healthcare insurance are anticipated to be the major factors contributing to the market growth. According to the Asthma and Allergy Foundation of America (AAFA), each year, over 50 million people experience various types of allergies causing it to be the 6th leading cause of chronic illness in the U.S.
CLICK TO DOWNLOAD A SAMPLE REPORT
An allergy is a reaction or hypersensitivity that is caused by the immune system when a body comes in the contact with any foreign substance. A trained professional conduct an allergy test to determine the presence of a foreign substance to which the immune might react in an affected body. There are different methods used for the detection of allergy such as biopsy and diagnostic test which is the most common form of test conducted in order to diagnose allergies.
The global allergy diagnostics market is segmented on the basis of product & service, tests, allergens, and end users. Based on allergens, the market is segmented into inhaled allergens, food allergens, drug allergens, and others. Among these segments, the inhaled allergens segment is expected to hold the largest market share during the forecast period by growing at a moderate CAGR. The growth of the inhaled allergens segment can be attributed to the increasing incidences of respiratory allergies such as asthma, growing demand for allergy testing, increasing environmental pollution, and rising cases of pollen allergy.
Global Allergy Diagnostics Market Regional Synopsis
Regionally, the global allergy diagnostics market is segmented into five major regions including North America, Europe, Asia Pacific, Latin America, and the Middle East & Africa region. The market in North America region witnessed a modest growth in the year 2021 on the account of increasing incidences of allergic diseases, environmental pollution, and the presence of key market players in the region. Additionally, the market in the Europe region also contributed moderately in the previous year. On the other hand, the market in the Asia Pacific region is estimated to hold the largest market share during the forecast period on the back of improvement in life sciences research and growing governmental initiatives to spread awareness about allergy diagnostics. Moreover, the growing geriatric population and rising incidences of allergic conditions are major factors contributing to the growth of the market. In the Asia Pacific region, food allergy accounts to the most common allergic disease which affects around 10% of the population in the region.
Market Segmentation
Our in-depth analysis of the global allergy diagnostics market includes the following segments:
By Product and Service
-
Assay Kits
-
Instruments
-
Services
-
Consumables
By Tests
-
In-Vivo Tests
-
In-Vitro Tests
By Allergens
-
Inhaled Allergens
-
Food Allergens
-
Drug Allergens
-
Others
By End Users
-
Diagnostic Laboratories
-
Hospital-Based Laboratories
-
Academic Research Institutes
-
Others
Growth Drivers and Challenges Impacting the Growth of the Global Allergy Diagnostics Market
Growth Drivers
-
Increasing cases of allergies
-
Rising level of environmental pollutions
-
Improving healthcare infrastructure
Challenges
-
High cost of diagnostic instruments
-
Lack of trained professionals
-
Lack of awareness about allergy-related diseases
Key Companies Dominating the Global Allergy Diagnostics Market
Our report has covered detailed company profiling comprising company overview, business strategies, key product offerings, financial performance, key performance indicators, risk analysis, recent developments, regional presence, and SWOT analysis among other notable indicators for competitive positioning. Some of the prominent industry leaders in the global allergy diagnostics market that are included in our report are Allergy Therapeutics, Lincoln Diagnostics, Inc., Showa Denko Materials Co., Ltd., Demeditec Diagnostics GmbH, Danaher, Omega Diagnostics Group PLC, bioMérieux, Inc., HYCOR Biomedical, PerkinElmer, Inc. (EUROIMMUN Medizinische Labordiagnostika AG), Tecan Trading AG, THERADIAG, and others.
Latest Developments in the Global Allergy Diagnostics Market:
-
13 April 2021: Showa Denko Materials Co., Ltd. announced the transformation of Hitachi Chemical Diagnostics Systems Co., Ltd., a consolidated subsidiary of Showa Denko Materials to a fully owned subsidiary. The conversion will also include the acquisition of all common shares of HKDS that are owned by Kyowa Kirin Co., Ltd.
-
30 August 2021: Danaher Corporation, a global science, and technology innovator company, announced the completion of acquisition of Aldevron. Wherein, Danaher's Life Sciences segment will allow Aldevron to operate as a standalone operating company.
Key Reasons to Buy Our Report
-
The report covers detailed analysis comprising market share attained by each market segment and its sub-segments.
-
It covers market dynamics including growth drivers, trends, potential opportunities, price trend analysis and challenges that impact the market growth.
-
The report includes detailed company profiles of the major players dominating the market.
-
We use effective research methodologies to calculate the market numbers and provide value-added assessment for overall growth.
-
We provide customized reports as per the clients’ requirement helping them to see possible and unexpected challenges and unforeseen opportunities in order to help them reach their goal.
Geography Analysis:
The report further discusses the market opportunity, compound annual growth rate (CAGR) growth rate, competition, new technology innovations, market players analysis, government guidelines, export and import (EXIM) analysis, historical revenues, future forecasts etc. in the following regions and/or countries:
- North America (U.S. & Canada) Market Size, Y-O-Y Growth, Market Players Analysis & Opportunity Outlook
- Latin America (Brazil, Mexico, Argentina, Rest of Latin America) Market Size, Y-O-Y Growth & Market Players Analysis & Opportunity Outlook
- Europe (U.K., Germany, France, Italy, Spain, Hungary, Belgium, Netherlands & Luxembourg, NORDIC(Finland, Sweden, Norway, Denmark), Ireland, Switzerland, Austria, Poland, Turkey, Russia, Rest of Europe), Poland, Turkey, Russia, Rest of Europe) Market Size, Y-O-Y Growth Market Players Analys & Opportunity Outlook
- Asia-Pacific (China, India, Japan, South Korea, Singapore, Indonesia, Malaysia, Australia, New Zealand, Rest of Asia-Pacific) Market Size, Y-O-Y Growth & Market Players Analysis & Opportunity Outlook
- Middle East and Africa (Israel, GCC (Saudi Arabia, UAE, Bahrain, Kuwait, Qatar, Oman), North Africa, South Africa, Rest of Middle East and Africa) Market Size, Y-O-Y Growth Market Players Analysis & Opportunity Outlook
.
FREQUENTLY ASKED QUESTIONS
The increasing cases of allergies, rising levels of environmental pollutions, and improving healthcare infrastructure are the major factors driving the growth of the market.
The market is anticipated to attain a CAGR of ~13% over the forecast period, i.e., 2022 – 2031.
High cost of diagnostic instruments, lack of trained professionals, and lack of awareness about allergy related diseases are estimated to hamper the market growth.
The Asia Pacific region will provide more business opportunities for growth of allergy diagnostics market in future.
The major players in the market are Allergy Therapeutics, Lincoln Diagnostics, Inc., Showa Denko Materials Co., Ltd., Demeditec Diagnostics GmbH, Danaher, Omega Diagnostics Group PLC, bioMérieux Inc., HYCOR Biomedical, and others.
The company profiles are selected based on the revenues generated from the product segment, geographical presence of the company which determine the revenue generating capacity as well as the new products being launched into the market by the company.
The market is segmented by product & service, tests, allergens, end users, and by region.
The inhaled allergens segment is anticipated to hold largest market size in value and is estimated grow at a moderate CAGR over the forecast period and display significant growth opportunities.
Please enter your personal details below
- Allergy Therapeutics,
- Lincoln Diagnostics Inc.,
- Showa Denko Materials Co., Ltd.
- Demeditec Diagnostics GmbH
- Danaher
- Omega Diagnostics Group PLC
- bioMérieux Inc.,
- HYCOR Biomedical
- PerkinElmer Inc. (EUROIMMUN Medizinische Labordiagnostika AG)
- Tecan Trading AG
- THERADIAG